Results

Total Results: 628 records

Showing results for "prescribed".

421. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_2012-12-11.pdf
     January 01, 2012 - Obesity AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 10: Obesity Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov Contract No. HHSA290…

422. Disposition of Comments Report for Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
     September 25, 2013 - a population of convenience for measuring the effect since the antiplatelet therapy in question is prescribed … testing because it is a well‐ characterized and widely available population where P2Y12 inhibitors are prescribed

423. Automated-Entry Patient Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-generated-health-data-protocol-chronic-conditions.pdf
     March 17, 2020 - Automated-Entry Patient Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes Evidence-based Practice Center Technical Brief Protocol Project Title: Automated-Entry Patient Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes Initial Publication Date: Dec…

424. CER 215 Executive Summary: Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-executive-summary.pdf
     March 01, 2019 - CER 215 Executive Summary: Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults Purpose of Review To assess adverse events of antidepressants in the treatment of major depressive disorder in adults 65 years of age or older. Key Messages In people 65 years of age or older: • Serotoni…

425. Cancer-Ovarian-Contraceptives Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
     June 01, 2013 - These results may be reassuring to women considering OCs for contraception and to women who are prescribed

426. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - suicide risk because of its rapid action, and changing care setting from outpatient oral therapy prescribed

427. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
     March 10, 2010 - columns From the new label: Elderly patients are at higher risk of myopathy and CRESTOR should be prescribed

428. Diagnosis of Attention-Deficit/Hyperactivity Disorder in Adults: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hyperactivity-disorder-protocol-amendment.pdf
     January 08, 2025 - Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature.

429. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hyperactivity-disorder-protocol.pdf
     November 10, 2024 - Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature.

430. S23 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s23.pdf
     October 01, 2007 - ORIGINAL ARTICLE Improving Depiction of Benefits and Harms Analyses of Studies of Well-Known Therapeutics and Review of High-Impact Medical Journals Artyom Sedrakyan, MD, PhD,*†‡ and Chuck Shih, MHS* Abstract: The issues of weighing benefits and harms and of shared decision-making have become increasingly important…

431. Research Protocol (Amended): Treatment of Acute Pain--An Evidence Map (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/acute-pain-protocol-amended.pdf
     June 10, 2018 - Research Protocol (Amended): Treatment of Acute Pain--An Evidence Map Evidence-based Practice Center Technical Brief Protocol Project Title: Treatment of Acute Pain – An Evidence Map I. Background and Objectives for the Technical Brief Addressing the opioid epidemic in the United States is a key prior…

432. Wheeled Mobility (Wheelchair) Service Delivery (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/wheelchair-service_disposition-comments.pdf
     January 01, 2012 - For example, standard mobility products are more often prescribed for individuals with diabetes, heart … Therefore there exists a group of individuals unable to obtain the most appropriate prescribed equipment

433. Urinary-Incontinence-Treatment Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/urinary-incontinence-treatment_research-protocol.pdf
     September 30, 2010 - - We defined as eligible all drugs prescribed to treat UI, including those that are not FDA-approved

434. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_june_2012.pdf
     January 01, 2012 - suicide risk because of its rapid action, and changing care setting from outpatient oral therapy prescribed

435. Disposition of Comments for Pharmacokinetic/Pharmacodynamic Measures for Guiding Antibiotic Treatment for Hospital-Acquired Pneumonia (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_disposition-comments.pdf
     November 24, 2014 - This could also translate into “sub-therapeutic” concentrations of antibiotics prescribed in sick patients

436. Defining an Optimal Format for Presenting Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-presentation-format_research.pdf
     January 01, 2019 - Defining an Optimal Format for Presenting Research Needs Methods Future Research Needs Report Number 3 Defining an Optimal Format for Presenting Research Needs Methods Future Research Needs Report Number 3 Defining an Optimal Format for Presenting Research Needs Pre…

437. Title (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-illness-adults-prisons_research-protocol.pdf
     September 13, 2012 - antidepressants (e.g., SSRIs), drugs such as amitriptyline (Elavil®) and imipramine (Tofranil®) are infrequently prescribed

438. Fibromyalgia Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fibromyalgia_executive.pdf
     January 01, 2015 - Clinical comorbidities, treatment patterns, and healthcare costs among patients with fibromyalgia newly prescribed

439. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
     May 01, 2010 - Once approval is given, however, the FDA does not regulate whether drugs are prescribed for off- label

440. Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-omega-3_research-protocol.pdf
     September 02, 2016 - continuous outcomes], and follow-up [the maximum follow up recorded]); the estimation procedure (the prescribed